LYMPHOMA

This study tested a combination of two drugs, isatuximab and cemiplimab, in people with certain types of lymphoma that had come back or not responded to other treatments. The goal was to see if the combination was safe and could shrink tumors. The trial was stopped early, but res…

This study tested the drug pembrolizumab in people with a hard-to-treat type of lymphoma (DLBCL) that has certain gene changes (PD-L1 alterations). The goal was to see if the drug could shrink tumors. However, the study was stopped early and only 5 people took part, so the result…

This study tested whether adding the targeted drug inotuzumab ozogamicin before and after a stem cell transplant could help control leukemia and lymphoma. The drug attaches to cancer cells and delivers chemotherapy directly to them. The study included 15 people aged 12 to 75 with…

This study tested a combination of two immunotherapy drugs (nivolumab and ipilimumab) given after a stem cell transplant in people with high-risk multiple myeloma or lymphoma. The goal was to see if this approach is safe and can help prevent the cancer from coming back. The study…

This study tested whether the drug ofatumumab could control small amounts of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that remain after chemotherapy. It enrolled only 4 adults who had finished chemo but still had signs of disease. The study was termi…

This study tested a combination of two drugs, pembrolizumab and CMP-001, in 14 adults with lymphoma that had returned or stopped responding to prior treatments. The goal was to find a safe and effective dose to shrink tumors. The trial was terminated early, so results are limited…

This study tested a combination of two drugs, umbralisib and rituximab, as the first treatment for people with follicular lymphoma or marginal zone lymphoma. The goal was to see how many patients had their cancer completely disappear. The study was stopped early and included 18 a…

This study tested a digital tool that appears on the lock screen of an Android phone to encourage physical activity in cancer survivors. Participants used the app and wore a Fitbit for 3 months, with follow-up at 6 months. The goal was to see if the app could increase activity an…

This study tested a sensory rehabilitation program for adults with blood cancers (like lymphoma or multiple myeloma) who had smell and taste problems after finishing chemotherapy. The program used special sprays and exercises to retrain the senses. Only 5 people enrolled before t…

This study tested a method to guide surgical biopsies of lymph nodes in the abdomen using real-time imaging. The goal was to make the procedure safer and more accurate. Only 11 people took part before the study was stopped early.

This study created a registry for people who survived cancer as young adults (ages 18-39). Researchers wanted to understand their levels of depression, anxiety, social support, and financial stress. Participants filled out online surveys every 6 to 12 months. The registry also he…